You are using an unsupported browser. Please update your browser to the latest version on or before July 31, 2020.
close
Home > Video > What is Druggable New Therapeutic Targets in Rare Disease
What is Druggable New Therapeutic Targets in Rare Disease
print icon

Only a fraction of the more than 7,000 rare diseases identified have approved therapies available. Advances in DNA sequencing have led to the identification of the genetic cause of several rare diseases, which can potentially lead to a better understanding of the disease and development of targeted therapies. Hear from experts that have a pulse on new therapeutic targets in rare disease.

 

Speakers: Jason Sicklick, MD, Ye Liu, PhD

 

Feedback
0 out of 0 found this helpful

scroll to top icon